Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocugen (OCGN) Cash & Equivalents (2016 - 2024)

Ocugen (OCGN) has disclosed Cash & Equivalents for 11 consecutive years, with $15.7 million as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Cash & Equivalents fell 77.76% year-over-year to $15.7 million, compared with a TTM value of $15.7 million through Jun 2024, down 77.76%, and an annual FY2023 reading of $39.5 million, down 49.12% over the prior year.
  • Cash & Equivalents was $15.7 million for Q2 2024 at Ocugen, down from $26.4 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $129.8 million in Q1 2022 and bottomed at $3.2 million in Q1 2020.
  • Average Cash & Equivalents over 5 years is $62.3 million, with a median of $60.9 million recorded in 2023.
  • The sharpest move saw Cash & Equivalents skyrocketed 2106.07% in 2020, then crashed 77.76% in 2024.
  • Year by year, Cash & Equivalents stood at $24.0 million in 2020, then surged by 295.02% to $95.0 million in 2021, then dropped by 18.32% to $77.6 million in 2022, then plummeted by 49.12% to $39.5 million in 2023, then tumbled by 60.22% to $15.7 million in 2024.
  • Business Quant data shows Cash & Equivalents for OCGN at $15.7 million in Q2 2024, $26.4 million in Q1 2024, and $39.5 million in Q4 2023.